3D-QSAR of histone deacetylase inhibitors as anticancer agents by genetic function approximation

被引:0
|
作者
Wagh, Nilesh K. [1 ]
Deokar, Hemantkumar S. [1 ]
Juvale, Dhanshri C. [1 ]
Kadam, Shivajirao S. [1 ]
Kulkarni, Vithal M. [1 ]
机构
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Chem, Pune 411038, Maharashtra, India
来源
关键词
3D-QSAR; genetic function approximation; anticancer agents; histone deacetylases; hydroxamic acid analogues; physico-chemical descriptors;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone deacetylases (HDACs) play a critical role in gene transcription and are implicated in cancer therapy and other diseases. Inhibitors of HDACs induce cell differentiation and suppress cell proliferation in the tumour cells. Athough many such inhibitors have been designed and synthesized, but selective inhibitors for HDAC isoforms are lacking. Various hydroxamic acid analogues have been reported as HDAC inhibitors. Here, we report a three-dimensional quantitative structure-activity relationship (3D-QSAR) Study performed using genetic function approximation (GFA) for this class of molecules. QSAR models were generated using a training set of 39 molecules and the predictive ability of final model was assessed using a test set of 17 molecules. The internal consistency of the final QSAR model was 0.712 and showed good external predictivity of 0.585. The results of the present QSAR study indicated that molecular shape analysis (MSA), thermodynamic and structural descriptors are important for inhibition of HDACs.
引用
收藏
页码:360 / 371
页数:12
相关论文
共 50 条
  • [31] New histone deacetylase inhibitors and anticancer agents from Curcuma longa
    Pakit Kumboonma
    Thanaset Senawong
    Somprasong Saenglee
    Gulsiri Senawong
    La-or Somsakeesit
    Chavi Yenjai
    Chanokbhorn Phaosiri
    Medicinal Chemistry Research, 2019, 28 : 1773 - 1782
  • [32] New histone deacetylase inhibitors and anticancer agents from Curcuma longa
    Kumboonma, Pakit
    Senawong, Thanaset
    Saenglee, Somprasong
    Senawong, Gulsiri
    Somsakeesit, La-or
    Yenjai, Chavi
    Phaosiri, Chanokbhorn
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (10) : 1773 - 1782
  • [33] Histone deacetylase inhibitors: A new wave of molecular targeted anticancer agents
    Budillon, Alfredo
    Di Gennaro, Elena
    Bruzzese, Francesca
    Rocco, Monia
    Manzo, Giuseppe
    Caraglia, Michele
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (02) : 119 - 134
  • [34] Synthesis of hybrid anticancer agents based on kinase and histone deacetylase inhibitors
    Patel, Hiren
    Chuckowree, Irina
    Coxhead, Peter
    Guille, Matthew
    Wang, Minghua
    Zuckermann, Alexandra
    Williams, Robin S. B.
    Librizzi, Mariangela
    Paranal, Ronald M.
    Bradner, James E.
    Spencer, John
    MEDCHEMCOMM, 2014, 5 (12) : 1829 - 1833
  • [35] Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents
    El-Awady, Raafat
    Saleh, Ekram
    Hamoudi, Rifat
    Ramadan, Wafaa S.
    Mazitschek, Ralph
    Nael, Manal A.
    Elokely, Khaled M.
    Abou-Gharbia, Magid
    Childers, Wayne E.
    Srinivasulu, Vunnam
    Aloum, Lujain
    Menon, Varsha
    Al-Tel, Taleb H.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 42
  • [36] Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
    Mottamal, Madhusoodanan
    Zheng, Shilong
    Huang, Tien L.
    Wang, Guangdi
    MOLECULES, 2015, 20 (03) : 3898 - 3941
  • [37] Anticancer activities of histone deacetylase inhibitors
    Jessica E. Bolden
    Melissa J. Peart
    Ricky W. Johnstone
    Nature Reviews Drug Discovery, 2006, 5 : 769 - 784
  • [38] Histone deacetylase inhibitors: Anticancer compounds
    Smith, Karen T.
    Workman, Jerry L.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (01): : 21 - 25
  • [39] Histone Deacetylase Inhibitors as Anticancer Drugs
    Eckschlager, Tomas
    Plch, Johana
    Stiborova, Marie
    Hrabeta, Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [40] Anticancer activities of histone deacetylase inhibitors
    Bolden, Jessica E.
    Peart, Melissa J.
    Johnstone, Ricky W.
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) : 769 - 784